A detailed history of Rbf Capital, LLC transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, Rbf Capital, LLC holds 165,474 shares of RLMD stock, worth $62,880. This represents 0.03% of its overall portfolio holdings.

Number of Shares
165,474
Previous 165,474 -0.0%
Holding current value
$62,880
Previous $496,000 8.06%
% of portfolio
0.03%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$2.45 - $4.22 $70,070 - $120,692
-28,600 Reduced 14.74%
165,474 $685,000
Q2 2023

Aug 14, 2023

BUY
$2.22 - $3.54 $430,844 - $687,021
194,074 New
194,074 $477,000

Others Institutions Holding RLMD

About RELMADA THERAPEUTICS, INC.


  • Ticker RLMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,608,500
  • Market Cap $10.9M
  • Description
  • Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...
More about RLMD
Track This Portfolio

Track Rbf Capital, LLC Portfolio

Follow Rbf Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rbf Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rbf Capital, LLC with notifications on news.